The FDA has approved the oral antiviral Xocova (ensitrelvir) for postexposure prophylaxis of COVID-19 in adults and adolescents.
The 2026 epidemic of Ebola virus disease caused by Bundibugyo virus (species Orthoebolavirus bundibugyoense) in DR Congo and Uganda has been declared a public health emergency of international concern ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results